AHCO
AdaptHealth Corp.
Overview
AdaptHealth provides home medical equipment, medical supplies, and related services to patients across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home.
AdaptHealth Corp is a Healthcare company operating in Medical Devices with a $1.31B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0511 Q&A exchanges
- Q4 FY2025Earnings2026-02-2411 Q&A exchanges
- Q3 FY2025Earnings2025-11-049 Q&A exchanges
- Q2 FY2025Earnings2025-08-0511 Q&A exchanges
- Q1 FY2025Earnings2025-05-0623 Q&A exchanges
- Q4 FY2024Earnings2025-02-2521 Q&A exchanges
- Q3 FY2024Earnings2024-11-0523 Q&A exchanges
- Q2 FY2024Earnings2024-08-0620 Q&A exchanges
- Q1 FY2024Earnings2024-05-0729 Q&A exchanges
- Q4 FY2023Earnings2024-02-2734 Q&A exchanges
- Q3 FY2023Earnings2023-11-0723 Q&A exchanges
- Q2 FY2023Earnings2023-08-0820 Q&A exchanges
- Q1 FY2023Earnings2023-05-0920 Q&A exchanges
- Q4 FY2022Earnings2023-02-2813 Q&A exchanges
- Q3 FY2022Earnings2022-11-0835 Q&A exchanges
- Q2 FY2022Earnings2022-08-0922 Q&A exchanges
- Q1 FY2022Earnings2022-05-1421 Q&A exchanges
- Q4 FY2021Earnings2022-02-2617 Q&A exchanges
- Q3 FY2021Earnings2021-11-0618 Q&A exchanges
- Q2 FY2021Earnings2021-08-0826 Q&A exchanges
- Q1 FY2021Earnings2021-05-0929 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.01—Rev— vs ——EODHD
- Q1 FY20262026-05-11EPS$-0.05 vs $0.05-100.0%Rev$819.8M vs ——EODHD
- Q4 FY20252026-02-23EPS$0.27 vs $0.36-25.4%Rev$846.3M vs ——EODHD
- Q3 FY20252025-11-03EPS$0.16 vs $0.24-33.3%Rev$602.6M vs ——EODHD
- Q2 FY20252025-08-04EPS$0.22 vs $0.16+36.2%Rev$591.8M vs ——EODHD
- Q1 FY20252025-05-04EPS$-0.05 vs $0.04-100.0%Rev$580.5M vs ——EODHD
- Q4 FY20242025-02-24EPS$0.42 vs $0.28+49.3%Rev$856.6M vs ——EODHD
- Q3 FY20242024-11-04EPS$0.15 vs $0.17-9.8%Rev$597.5M vs ——EODHD
- Q2 FY20242024-08-05EPS$0.13 vs $0.16-18.8%Rev$595.0M vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.02 vs $0.05-100.0%Rev$594.1M vs ——EODHD
- Q4 FY20232024-02-26EPS$-1.91 vs $0.18-100.0%Rev$1.48B vs ——EODHD
- Q3 FY20232023-11-06EPS$0.42 vs $0.19+100.0%Rev$583.7M vs ——EODHD
- Q2 FY20232023-08-07EPS$0.09 vs $0.10-10.0%Rev$583.6M vs ——EODHD
- Q1 FY20232023-05-08EPS$0.11 vs $0.08+37.5%Rev$744.6M vs ——EODHD
- Q4 FY20222023-02-26EPS$-0.02 vs $0.28-100.0%Rev$1.36B vs ——EODHD
- Q3 FY20222022-11-07EPS$0.11 vs $0.31-64.5%Rev$557.7M vs ——EODHD
- Q2 FY20222022-08-08EPS$0.09 vs $0.26-65.4%Rev$531.3M vs ——EODHD
- Q1 FY20222022-05-09EPS$0.08 vs $0.18-55.6%Rev$524.6M vs ——EODHD
- Q4 FY20212022-02-23EPS$0.17 vs $0.34-50.0%Rev$702.1M vs ——EODHD
- Q3 FY20212021-11-03EPS$0.20 vs $0.28-28.6%Rev$472.8M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.01 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-11 | $-0.05 | $0.05 | -100.0% | $819.8M | — | — | EODHD |
| Q4 FY2025 | 2026-02-23 | $0.27 | $0.36 | -25.4% | $846.3M | — | — | EODHD |
| Q3 FY2025 | 2025-11-03 | $0.16 | $0.24 | -33.3% | $602.6M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $0.22 | $0.16 | +36.2% | $591.8M | — | — | EODHD |
| Q1 FY2025 | 2025-05-04 | $-0.05 | $0.04 | -100.0% | $580.5M | — | — | EODHD |
| Q4 FY2024 | 2025-02-24 | $0.42 | $0.28 | +49.3% | $856.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-04 | $0.15 | $0.17 | -9.8% | $597.5M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $0.13 | $0.16 | -18.8% | $595.0M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.02 | $0.05 | -100.0% | $594.1M | — | — | EODHD |
| Q4 FY2023 | 2024-02-26 | $-1.91 | $0.18 | -100.0% | $1.48B | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $0.42 | $0.19 | +100.0% | $583.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $0.09 | $0.10 | -10.0% | $583.6M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $0.11 | $0.08 | +37.5% | $744.6M | — | — | EODHD |
| Q4 FY2022 | 2023-02-26 | $-0.02 | $0.28 | -100.0% | $1.36B | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $0.11 | $0.31 | -64.5% | $557.7M | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $0.09 | $0.26 | -65.4% | $531.3M | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $0.08 | $0.18 | -55.6% | $524.6M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $0.17 | $0.34 | -50.0% | $702.1M | — | — | EODHD |
| Q3 FY2021 | 2021-11-03 | $0.20 | $0.28 | -28.6% | $472.8M | — | — | EODHD |
Source: EODHD. AHCO reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks AHCO's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 6/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Missed in 3 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.76 | $1.57 | +11.8% | +1.8% | +3.0% |
| Q4 FY2026 | $1.39 | $1.41 | -1.7% | -7.4% | -7.5% |
| Q3 FY2026 | $1.59 | $1.64 | -3.0% | -8.4% | -6.5% |
| Q2 FY2026 | $1.69 | $1.73 | -2.5% | +1.4% | +2.5% |
| Q1 FY2025 | $1.73 | $1.68 | +2.9% | -8.7% | -6.3% |
| Q4 FY2025 | $1.53 | $1.57 | -2.3% | +2.5% | +0.8% |
| Q3 FY2025 | $1.60 | $1.51 | +5.8% | -8.6% | -8.0% |
| Q2 FY2025 | $1.80 | $1.79 | +0.5% | -6.5% | -6.3% |
| Q1 FY2024 | $1.82 | $1.70 | +6.9% | -2.6% | -2.7% |
| Q4 FY2024 | $1.74 | $1.66 | +4.8% | +0.5% | -0.8% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Maintained2026-13-15
- Q3 FY2026Maintained2026-10-15
- Q2 FY2026Suspended2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Maintained2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Suzanne FosterCEO1 yr 4 mo8 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Jason A ClemensCFO1 yr 6 mo21 callsCurrentSample
CFO since 2024 • 4/8 beats (50%) • last guidance raise Q3 FY2026
- Toby Scott BarnhartCOO1 yr 4 mono recorded callsCurrentSample
COO since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
- Albert A PrastChief Technology Officer1 yr 4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance cut Q1 FY2026
- Christine E ArchboldChief Accounting Officer1 yr 4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q1 FY2026
- Richard W Rew IICLO and General Counsel1 yr 5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AHCO.
$ curl https://api.spokenalpha.com/v1/companies/AHCOFAQ
Frequently asked about AHCO
Where can I find AdaptHealth Corp.'s (AHCO) earnings call transcripts?
Spoken Alpha indexes AHCO's earnings call transcripts at https://spokenalpha.com/companies/AHCO. Each call links to attributed speakers and parsed analyst Q&A.
When was AdaptHealth Corp.'s most recent earnings call?
AdaptHealth Corp. (AHCO) held its most recent earnings call on 2026-05-05, covering fiscal Q1 2026.
What sector is AHCO in?
AdaptHealth Corp. (AHCO) operates in the Healthcare sector (Medical Devices industry).